Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptive Biotechnologies Corp

7.56
+0.21002.86%
Post-market: 7.50-0.0600-0.79%19:40 EDT
Volume:1.83M
Turnover:14.04M
Market Cap:1.12B
PE:-6.97
High:8.08
Open:7.30
Low:7.26
Close:7.35
Loading ...

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
12 Feb

Adaptive Biotechnologies' Q4 Loss Narrows, Revenue Rises

MT Newswires Live
·
12 Feb

Adaptive Biotechnologies: Q4 Earnings Snapshot

Associated Press Finance
·
12 Feb

Adaptive Biotechnologies Q4 2024 GAAP EPS $(0.23) Beats $(0.26) Estimate, Sales $47.459M Beat $46.034M Estimate

Benzinga
·
12 Feb

BRIEF-Adaptive Biotechnologies Q4 EPS USD -0.23

Reuters
·
12 Feb

Adaptive Biotechnologies Q4 Revenue USD 47.459 Million VS. Ibes Estimate USD 46 Million

THOMSON REUTERS
·
12 Feb

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
10 Feb

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

GlobeNewswire
·
06 Feb

The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99%

Simply Wall St.
·
29 Jan

Adaptive Biotechnologies Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
28 Jan

Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing Now

Insider Monkey
·
24 Jan

Why Is Andreas Halvorsen Bullish On Adaptive Biotechnologies Corporation (ADPT) Now?

Insider Monkey
·
23 Jan

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

GlobeNewswire
·
23 Jan

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Zacks
·
17 Jan

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

Zacks
·
16 Jan